当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析 - 利润表

药明康德

(603259)

  

流通市值:2827.06亿  总市值:3280.84亿
流通股本:25.47亿   总股本:29.56亿

利润表

按照会计年度查询:
报告期2021-09-302021-06-302021-03-312020-12-31
一、营业总收入16,521,369,391.3710,536,557,946.984,950,479,646.7316,535,431,465.41
营业收入16,521,369,391.3710,536,557,946.984,950,479,646.7316,535,431,465.41
二、营业总成本13,137,666,500.638,454,154,796.293,996,298,821.513,928,304,273.31
营业成本10,410,754,419.196,639,256,903.523,113,892,231.2110,253,275,738.89
营业税金及附加33,881,553.5323,758,156.8911,148,414.9834,504,967.7
销售费用497,157,806.57355,259,383.68158,557,564.92588,459,299.32
管理费用1,505,726,229.89971,607,531.47475,746,512.11,839,000,399.44
财务费用45,940,603.959,841,553.3432,378,080.95519,804,239.36
资产减值损失-19,721,174.11-9,347,142.543,549,126.28-62,641,873.62
三、其他经营收益-396,270,807.97-277,142,315.93-103,064,283.6287,649,859.02
允许价值变动净收益-547,860,299.26-27,069,272.2211,808,047.0252,271,444.73
投资净收益1,374,368,868.831,052,300,762.49483,772,891.12606,231,164.3
联营、合营企业投资收益-3,628,628.9194,992,395.61-28,416,448-90,751,984.66
汇兑净收益--------
四、营业利润4,302,311,952.743,186,849,397.11,697,539,566.193,389,484,982.27
营业外收入6,507,568.774,237,018.033,411,377.515,450,731.5
营业外支出26,147,910.8611,151,627.755,057,146.5925,560,017.86
非流动资产处置净损失--------
五、利润总额4,282,671,610.653,179,934,787.381,695,893,797.113,369,375,695.91
所得税694,427,828.13487,741,755.17188,789,073.54383,125,594.56
未确认的投资损失--------
六、净利润(百万元)3,562.232,675.11,499.812,960.24
少数股东损益26,016,845.9917,092,422.567,299,318.3126,014,605.47
归属于母公司股东的净利润3,562,226,936.532,675,100,609.651,499,805,405.262,960,235,495.88
七、每股收益--0.920.621.27
基本每股收益1.220.920.621.27
稀释每股收益1.210.910.611.25
TOP↑